These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 8937858

  • 1. Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague-Dawley rats and beagle dogs. Effect of bile duct cannulation on excretion pathways.
    Dalvie DK, Khosla NB, Navetta KA, Brighty KE.
    Drug Metab Dispos; 1996 Nov; 24(11):1231-40. PubMed ID: 8937858
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
    Zhang D, Wang L, Raghavan N, Zhang H, Li W, Cheng PT, Yao M, Zhang L, Zhu M, Bonacorsi S, Yeola S, Mitroka J, Hariharan N, Hosagrahara V, Chandrasena G, Shyu WC, Humphreys WG.
    Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
    [Abstract] [Full Text] [Related]

  • 7. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K, Okabe H, Sugeno K, Misaki A, Ito M, Kominami G, Esumi Y, Takaichi M, Harada T, Seki H, Inaba A.
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys.
    Teng R, Girard D, Gootz TD, Foulds G, Liston TE.
    Antimicrob Agents Chemother; 1996 Mar; 40(3):561-6. PubMed ID: 8851571
    [Abstract] [Full Text] [Related]

  • 9. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
    Balani SK, Woolf EJ, Hoagland VL, Sturgill MG, Deutsch PJ, Yeh KC, Lin JH.
    Drug Metab Dispos; 1996 Dec; 24(12):1389-94. PubMed ID: 8971147
    [Abstract] [Full Text] [Related]

  • 10. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.
    Zhang D, He K, Raghavan N, Wang L, Mitroka J, Maxwell BD, Knabb RM, Frost C, Schuster A, Hao F, Gu Z, Humphreys WG, Grossman SJ.
    Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130
    [Abstract] [Full Text] [Related]

  • 11. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
    Huskey SE, Dean BJ, Doss GA, Wang Z, Hop CE, Anari R, Finke PE, Robichaud AJ, Zhang M, Wang B, Strauss JR, Cunningham PK, Feeney WP, Franklin RB, Baillie TA, Chiu SH.
    Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
    [Abstract] [Full Text] [Related]

  • 12. Reductive isoxazole ring opening of the anticoagulant razaxaban is the major metabolic clearance pathway in rats and dogs.
    Zhang D, Raghavan N, Chen SY, Zhang H, Quan M, Lecureux L, Patrone LM, Lam PY, Bonacorsi SJ, Knabb RM, Skiles GL, He K.
    Drug Metab Dispos; 2008 Feb; 36(2):303-15. PubMed ID: 17984286
    [Abstract] [Full Text] [Related]

  • 13. Metabolism, distribution, and excretion of a next generation selective estrogen receptor modulator, lasofoxifene, in rats and monkeys.
    Prakash C, Johnson KA, Schroeder CM, Potchoiba MJ.
    Drug Metab Dispos; 2008 Sep; 36(9):1753-69. PubMed ID: 18515329
    [Abstract] [Full Text] [Related]

  • 14. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.
    Denissen JF, Grabowski BA, Johnson MK, Buko AM, Kempf DJ, Thomas SB, Surber BW.
    Drug Metab Dispos; 1997 Apr; 25(4):489-501. PubMed ID: 9107549
    [Abstract] [Full Text] [Related]

  • 15. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys.
    Emary WB, Toren PC, Mathews B, Huh K.
    Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285
    [Abstract] [Full Text] [Related]

  • 16. Glucuronidation as a transient intermediate metabolic step in the elimination of (-)-carbovir. Identification of (-)-carbovir-5'-O-glucuronide in rat bile.
    Zimmerman CL, Iyer KR, Faudskar AL, Remmel RP.
    Drug Metab Dispos; 1993 Aug; 21(5):902-10. PubMed ID: 7902254
    [Abstract] [Full Text] [Related]

  • 17. Metabolism and disposition of [14C]BMS-690514 after oral administration to rats, rabbits, and dogs.
    Hong H, Su H, Sun H, Allentoff A, Ekhato IV, Chando T, Caceres-Cortes J, Roongta V, Iyer RA, Humphreys WG, Christopher LJ.
    Drug Metab Dispos; 2010 Jul; 38(7):1189-201. PubMed ID: 20363952
    [Abstract] [Full Text] [Related]

  • 18. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C, Cui D.
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [Abstract] [Full Text] [Related]

  • 19. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
    Mamidi RN, Mannens G, Annaert P, Hendrickx J, Goris I, Bockx M, Janssen CG, Kao M, Kelley MF, Meuldermans W.
    Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
    [Abstract] [Full Text] [Related]

  • 20. The disposition of gemifloxacin, a new fluoroquinolone antibiotic, in rats and dogs.
    Ramji JV, Austin NE, Boyle GW, Chalker MH, Duncan G, Fairless AJ, Hollis FJ, McDonnell DF, Musick TJ, Shardlow PC.
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):435-42. PubMed ID: 11259328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.